Journal
NUCLEIC ACIDS RESEARCH
Volume 42, Issue 8, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gku117
Keywords
-
Categories
Funding
- Israel Science Foundation (ISF) [802/08, 317/13]
- Edmond J. Safra Center for Bioinformatics at Tel Aviv University
- Dan David Foundation
- Israeli Center for Research Excellence (I-CORE)
- Gene Regulation in Complex Human Disease
- center 41/11
- ISF [317/13]
- I-CORE
Ask authors/readers for more resources
Understanding gene regulation is a key challenge in today's biology. The new technologies of protein-binding microarrays (PBMs) and high-throughput SELEX (HT-SELEX) allow measurement of the binding intensities of one transcription factor (TF) to numerous synthetic double-stranded DNA sequences in a single experiment. Recently, Jolma et al. reported the results of 547 HT-SELEX experiments covering human and mouse TFs. Because 162 of these TFs were also covered by PBM technology, for the first time, a large-scale comparison between implementations of these two in vitro technologies is possible. Here we assessed the similarities and differences between binding models, represented as position weight matrices, inferred from PBM and HT-SELEX, and also measured how well these models predict in vivo binding. Our results show that HT-SELEX- and PBM-derived models agree for most TFs. For some TFs, the HT-SELEX-derived models are longer versions of the PBM-derived models, whereas for other TFs, the HT-SELEX models match the secondary PBM-derived models. Remarkably, PBM-based 8-mer ranking is more accurate than that of HT-SELEX, but models derived from HT-SELEX predict in vivo binding better. In addition, we reveal several biases in HT-SELEX data including nucleotide frequency bias, enrichment of C-rich k-mers and oligos and underrepresentation of palindromes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available